摘要
During the past 2 decades, large medical databases (big data) have been screened with powerful computing tools, through a so-called artificial intelligence (AI) process using machine learning and validation. This has led to a renewal of diabetes care. The main applications so far are screening and diagnosis (retinopathy, gestational diabetes, nonalcoholic steatohepatitis ( NASH)), therapeutic decision tool (strategy in type 2 diabetes) and predictive medicine (vascular risk). Diabetologists have a clinical expertise that should be employed to contribute to AI development, through the generation of quality data and adequate interpretation of outcomes.
学科与关键词
关键词
DiabetesArtificial intelligenceMachinelearningDatabasePrecision medicine
- Artificial intelligence for diabetes care: current and future prospectsSheng, Bin; Pushpanathan, Krithi; Guan, Zhouyu; Lim, Quan Hziung; Lim, Zhi Wei; Yew, Samantha Min Er; Goh, Jocelyn Hui Lin; Bee, Yong Mong; Sabanayagam, Charumathi; Sevdalis, Nick; Lim, Cynthia Ciwei; Lim, Chwee Teck; Shaw, Jonathan; Jia, Weiping; Ekinci, Elif Ilhan; Simo, Rafael; Lim, Lee-Ling; Li, Huating*; Tham, Yih-Chung*Lancet Diabetes & Endocrinology, 2024, 12(8): 569-595.被引 9
- Artificial intelligence and diabetes technology: A reviewGautier, Thibault*; Ziegler, Leah B.; Gerber, Matthew S.; Campos-Nanez, Enrique; Patek, Stephen D.Metabolism: Clinical and Experimental , 2021, 124: 154872.被引 27
- Artificial intelligence in diabetes management: Advancements, opportunities, and challengesGuan, Zhouyu; Li, Huating; Liu, Ruhan; Cai, Chun; Liu, Yuexing; Li, Jiajia; Wang, Xiangning; Huang, Shan; Wu, Liang; Liu, Dan; Yu, Shujie; Wang, Zheyuan; Shu, Jia; Hou, Xuhong; Yang, Xiaokang; Jia, Weiping*; Sheng, Bin*CELL REPORTS MEDICINE, 2023, 4(10): 101213.被引 48
